skip to main content

Levothyroxine ischaemic heart disease — GPhC CRA MCQ

Instant feedback + full explanation. One question, done properly.

ModerateEndocrine TherapeuticsLevothyroxine ischaemic heart diseaseGPhC CRA

A woman with hypothyroidism and ischaemic heart disease starts low-dose levothyroxine. What monitoring is required?

Educational content. Not a substitute for clinical judgement or local policy.

Reveal the answer and explanation

Correct answer: D — TSH and symptoms after an appropriate interval

This scenario assesses Levothyroxine ischaemic heart disease in a UK pharmacy practice context. Levothyroxine is titrated using thyroid function and symptoms, with caution in ischaemic heart disease. The best answer is TSH and symptoms after an appropriate interval because it addresses the principal clinical, legal or safety issue before routine supply. The other options are less appropriate because they either miss the key risk, delay necessary review, or would not meet expected BNF, NICE, MEP, MHRA or GPhC practice standards.

Reference: BNF; NICE CKS